Antifungal drugs can affect the cellular morphology of Cryptococcus neoformans in culture, which alters its interactions with phagocytes. We examined the effects of amphotericin B on C. neoformans during murine infection. The antifungal reduced capsule size and serum polysaccharide, which suggests an additional mechanism for amphotericin B’s efficacy in cryptococcosis. Cryptococcus neoformans is an encapsulated yeast-like fun-gus of worldwide distribution that is a relatively frequent cause of serious disease in immunocompromised patients. Ampho-tericin B (AMB) is recommended in combination with flucy-tosine for the treatment of cryptococcosis (16). AMB is pur-ported to mediate its antifungal effects by binding to cell membrane sterols and ...
ABSTRACT Cryptococcus neoformans is an encapsulated yeast responsible for approximately a quarter of...
The interaction of amphotericin B (AmB) and azole antifungal agents in the treatment of fungal infec...
The interaction of amphotericin B (AmB) and azole antifungal agents in the treatment of fungal infec...
We studied the effects of Amphotericin B (AmB) on Cryptococcus neoformans using different viability ...
Cryptococcus neoformans is a facultative intracellular pathogen responsible for the most common caus...
Amphotericin B acts through pore formation at the cell membrane after binding to ergosterol is an ac...
Cryptococcosis is a subacute or chronic systemic mycosis with a cosmopolitan nature, caused by yeast...
Cryptococcosis is a subacute or chronic systemic mycosis with a cosmopolitan nature, caused by yeast...
The incidence of opportunistic human pathogen Cryptococcus neoformans caused infections have been hi...
Cryptococcosis is a subacute or chronic systemic mycosis with a cosmopolitan nature, caused by yeast...
AbstractA natural and biocompatible fibrin microsphere is one of the most promising dual delivery ve...
Using two isogenic strains of Cryptococcus neoformans, we studied the influence of the capsule in C....
Cryptococcosis, caused by pathogenic yeasts of the Cryptococcus neoformans/ gattii complex, is a fun...
The interaction of amphotericin B (AmB) and azole antifungal agents in the treatment of fungal infec...
Using two isogenic strains of Cryptococcus neoformans, we studied the influence of the capsule in C....
ABSTRACT Cryptococcus neoformans is an encapsulated yeast responsible for approximately a quarter of...
The interaction of amphotericin B (AmB) and azole antifungal agents in the treatment of fungal infec...
The interaction of amphotericin B (AmB) and azole antifungal agents in the treatment of fungal infec...
We studied the effects of Amphotericin B (AmB) on Cryptococcus neoformans using different viability ...
Cryptococcus neoformans is a facultative intracellular pathogen responsible for the most common caus...
Amphotericin B acts through pore formation at the cell membrane after binding to ergosterol is an ac...
Cryptococcosis is a subacute or chronic systemic mycosis with a cosmopolitan nature, caused by yeast...
Cryptococcosis is a subacute or chronic systemic mycosis with a cosmopolitan nature, caused by yeast...
The incidence of opportunistic human pathogen Cryptococcus neoformans caused infections have been hi...
Cryptococcosis is a subacute or chronic systemic mycosis with a cosmopolitan nature, caused by yeast...
AbstractA natural and biocompatible fibrin microsphere is one of the most promising dual delivery ve...
Using two isogenic strains of Cryptococcus neoformans, we studied the influence of the capsule in C....
Cryptococcosis, caused by pathogenic yeasts of the Cryptococcus neoformans/ gattii complex, is a fun...
The interaction of amphotericin B (AmB) and azole antifungal agents in the treatment of fungal infec...
Using two isogenic strains of Cryptococcus neoformans, we studied the influence of the capsule in C....
ABSTRACT Cryptococcus neoformans is an encapsulated yeast responsible for approximately a quarter of...
The interaction of amphotericin B (AmB) and azole antifungal agents in the treatment of fungal infec...
The interaction of amphotericin B (AmB) and azole antifungal agents in the treatment of fungal infec...